Molecular cancer therapy: Cucurbitacin I (JSI-124) increases the expression of pro-apoptotic protein Fas ligand (FasL) via down regulation of its target gene, 4/May/2014, 11.26 am

Molecular cancer therapy: Cucurbitacin I (JSI-124) increases the expression of pro-apoptotic protein Fas ligand (FasL) via down regulation of its target gene, 4/May/2014, 11.26 am https://genomediscovery.org/wp-content/themes/fildisi/images/empty/thumbnail.jpg 150 150 https://genomediscovery.org/wp-content/themes/fildisi/images/empty/thumbnail.jpg May 4, 2014 May 4, 2014

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Molecular cancer therapy: Cucurbitacin I (JSI-124) increases the expression of pro-apoptotic protein Fas ligand (FasL) via down regulation of its target gene, 4/May/2014, 11.26 am, Genome-2-Bio-Medicine Discovery center (GBMD), ht tp://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org